19.02.2013 Views

Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>CMS</strong>-1403-FC<br />

drug add-on adjustment to the composite rate for CY 2009 is<br />

15.2 percent.<br />

TABLE 8: CY 2006, 2007 and 2008 ESRD Drug ASP Prices<br />

Independent Drugs CY 2006 CY 2007 CY 2008<br />

EPO $ 9.46 $ 9.17 $ 9.05<br />

Paricalcitol $ 3.81 $ 3.79 $ 3.78<br />

Sodium-ferric-glut $ 4.88 $ 4.76 $ 4.81<br />

Iron-sucrose $ 0.36 $ 0.37 $ 0.36<br />

Levocarnitine $ 9.44 $ 8.07 $ 6.31<br />

Doxercalciferol $ 2.97 $ 2.68 $ 2.75<br />

Calcitriol $ 0.55 $ 0.54 $ 0.40<br />

Iron-dextran $11.94 $11.69 $11.69<br />

Vancomycin $ 3.23 $ 3.43 $ 3.19<br />

Alteplase $31.63 $33.21 $33.06<br />

Aranesp $ 3.01 $ 3.29 $ 2.86<br />

TABLE 9: CY 2007 Drug Weights for ESRD Facilities<br />

Independent Drugs CY 2007 Weights<br />

EPO 69.1%<br />

Paricalcitol 11.9%<br />

Sodium-ferric-glut 2.5%<br />

Iron-sucrose 6.1%<br />

Levocarnitine 0.2%<br />

Doxercalciferol 2.8%<br />

Calcitriol 0.1%<br />

Iron-dextran 0.0%<br />

Vancomycin 0.1%<br />

Alteplase 1.0%<br />

Aranesp 6.2%<br />

5. Update to the Geographic Adjustments to the Composite<br />

Rates<br />

Section 1881(b)(12)(D) of the Act, as added by section<br />

623(d) of the MMA, gives the Secretary the authority to<br />

revise the wage indexes previously applied to the ESRD<br />

178

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!